Andexanet alfa
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Andexanet alfa and local guidelines before prescribing.
Specific reversal agent
Mechanism
Recombinant factor Xa decoy binding anti-Xa inhibitors.
Uses
Reversal of apixaban or rivaroxaban in life-threatening bleeding.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Thromboembolic events, infusion reactions.
Interactions
Specific to factor Xa inhibitors.
Contraindications and cautions
None specific
Monitoring
Bleeding, thrombosis
Pregnancy and breastfeeding
Use if life-threatening
Renal and hepatic impairment
No adjustment
Overdose and reversal
Not applicable
Special advice
Thrombosis risk; availability limited; prothrombin complex concentrate an alternative.
More from the textbook: uses, cautions and other points
- Reversal - idarucizumab (dabigatran); andexanet alfa or prothrombin complex concentrate (Xa inhibitors) - per local policy.
Cardiology: Anatomy Physiology and Pharmacology - Andexanet alfa is recommended by NICE (TA697) for adults with life-threatening or uncontrolled GI bleeding on apixaban or rivaroxaban.
Gastroenterology: Gastroenterology Emergencies (Complete) - PCC is used off-label where andexanet is not used.
Gastroenterology: Gastroenterology Emergencies (Complete) - Andexanet alfa | Life-threatening or uncontrolled GI bleeding on apixaban or rivaroxaban (NICE TA697).
Gastroenterology: Gastroenterology Emergencies (Complete) - Reverse anticoagulants: vitamin K with PCC for warfarin; andexanet for apixaban or rivaroxaban GI bleeds; idarucizumab for dabigatran.
Gastroenterology: Gastroenterology Emergencies (Complete) - NICE TA697: Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban
Gastroenterology: Gastroenterology Emergencies (Complete) - Blood pressure - long-term target systolic under about 130 mmHg after stroke (if tolerated); in acute intracerebral haemorrhage , lower systolic BP to about 130–140 mmHg within 6 hours (if over 150) and reverse anticoagulation urgently - prothrombin complex concentrate plus IV vitamin K (warfarin), idarucizumab (dabigatran), andexanet …
Neurology: Anatomy, Physiology and Pharmacology - Factor Xa inhibitors (apixaban, rivaroxaban, edoxaban): Follow local protocols - usually PCC. Andexanet is not NICE-recommended for intracranial haemorrhage.
Neurology: Stroke Emergencies
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Gastroenterology Emergencies (Complete) (5 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (5 mentions)
- Haematology: Emergencies (4 mentions)
- Haematology: Haemostasis and Thrombosis (4 mentions)
- Surgery: Major trauma and burns (1 mention)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (2 mentions)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Acute Medicine: The acute medical take (1 mention)
- Clinical imaging: Neuroimaging — head, brain and spine (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)